1.Advances on the toxicology and molecular mechanisms of different components of ambient fine particulate matter.
Ren Zhen PENG ; Zhou Zhou LI ; Yan Yi XU
Chinese Journal of Preventive Medicine 2022;56(5):645-651
Ambient fine particulate matters (PM2.5) refer to particulate matters with an aerodynamic diameter less than or equal to 2.5 μm. PM2.5 enter the body through the target organ-lung, and can induce a variety of adverse health effects (such as cardiovascular diseases, diabetes, respiratory diseases, neurodegenerative diseases and adverse birth outcomes). PM2.5 are known to have complex compositions (including water-soluble/-insoluble components and biological components), diverse sources and capacity of secondary transformation. Numerous epidemiological and toxicological studies indicated that different components of PM2.5 may induce adverse health effects through different biological mechanisms. In adddition, co-exposure of different components and their interaction should also be considered. Thus here we have systematically reviewed studies in recent years about the toxicological effects and underlying mechanisms of different components of ambient fine particulate matters, including inflammatory response, oxidative stress, endoplasmic reticulum stress, activation of the NF-κB signaling pathway and so on. The information may give some insights into the prevention and treatment of adverse health effects caused by exposure to different components of PM2.5.
Air Pollutants/toxicity*
;
Cardiovascular Diseases/chemically induced*
;
Humans
;
Lung
;
Oxidative Stress
;
Particulate Matter/toxicity*
2.Chest high-resolution CT features analysis in predicting the progression of asbestosis.
Shuang LI ; Na BAO ; Ya Li FAN ; Qiao YE
Chinese Journal of Industrial Hygiene and Occupational Diseases 2022;40(1):1-6
Objective: To analyze the radiological characteristics of chest high-resolution computed tomography (HRCT) of patients with asbestosis, and to investigate the signs of predicting the disease progression of asbestosis. Methods: A prospective method was used to enroll 68 patients with asbestosis who were regularly followed up from 2013 to 2016. The radiological characteristics of patients with asbestosis were described by the International Classification of HRCT for Occupational and Environmental Respiratory Diseases (ICOERD) , and the differences between patients with and without progression were compared during the observation period. The Cox proportional hazards regression model was used to analyze the chest HRCT radiological signs predicting the progression of asbestosis. Results: The study included 68 patients with asbestosis aged (65.5±7.8) years old, of which 64.7% (44/68) were female, 29.4% (20/68) had a history of smoking. There was no significant difference in age, sex, smoking and asbestos exposure between patients with progressive asbestosis (20.6%, 14/68) and patients without progressive asbestosis (79.4%, 54/68) (P>0.05) . Chest HRCT of patients with asbestosis showed irregular and/or linear opacities, of which 5.9% (4/68) were accompanied by honeycombing. Irregular and/or linear opacities were mainly lower lung preponderant, often accompanied with ground glass opacity and mosaic perfusion. 98.5% (67/68) had pleural abnormalities, of which 39.7% (27/68) had diffuse pleural thickening with parenchymal bands and/or rounded atelectasis. The analysis of multivariable Cox proportional hazard regression showed that the risk of the progression of asbestosis was increased with higher irregular and/or linears opacities cores (HR=1.184, 95%CI: 1.012-1.384, P=0.034) and the appearance of honeycombing (HR=6.488, 95%CI: 1.447-29.097, P=0.015) . Conclusion: The irregular and/or linear opacities scores and honeycombing on chest HRCT are independent influencing factors for predicting the disease progression of asbestosis.
Aged
;
Asbestos/adverse effects*
;
Asbestosis/diagnostic imaging*
;
Female
;
Humans
;
Lung
;
Middle Aged
;
Pleural Diseases/chemically induced*
;
Tomography, X-Ray Computed/methods*
3.Interstitial pneumonia in patients with diffuse large B-cell lymphoma receiving RCHOP and RCDOP regimens.
Yan Na MENG ; Shuo WANG ; Qing SHI ; Peng Peng XU ; Shu CHENG ; Li WANG ; Wei Li ZHAO
Chinese Journal of Hematology 2019;40(12):1015-1020
Objective: To identify the risk factors and clinical features associated with the interstitial pneumonia in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (RCHOP) or rituximab, cyclophosphamide, liposomal doxorubicin, vincristine and prednisone (RCDOP) regimens. Methods: A retrospective study was conducted in 836 patients with DLBCL admitted to the Department of Hematology at Ruijin Hospital from 2013 to 2018. Among them, 114 patients were treated with RCDOP regimen. Using the method of propensity score matching according to age, gender, IPI score of patients, 114 patients treated with RCHOP regimen were selected as controls. Clinical data, including comorbidities, gender, age, B symptoms, international prognostic index (IPI) score, disease stage, serum lactic dehydrogenase (LDH) and β(2) microglobulin (β(2)-MG) level were collected and the risk factors of interstitial pneumonia were further analyzed. Results: The interstitial pneumonia developed more frequently in RCDOP group than RCHOP group (28.95% vs 2.60%, P<0.01) . As the dose of liposomal doxorubicin elevated from 25-30 mg/m(2) to 35-40 mg/m(2), the incidence of interstitial pneumonia accordingly increased from 17.30% to 38.71% (P<0.05) . By multivariate analysis, disease stage was an independent factor of interstitial pneumonitis. Conclusions: Front line regimens containing liposomal doxorubicin in DLBCL patients link to a higher incidence of dose-dependent interstitial pneumonia. Prevention and surveillance should be emphasized in future studies.
Antineoplastic Combined Chemotherapy Protocols/adverse effects*
;
Cyclophosphamide
;
Doxorubicin
;
Humans
;
Lung Diseases, Interstitial/chemically induced*
;
Lymphoma, Large B-Cell, Diffuse/drug therapy*
;
Prednisone
;
Retrospective Studies
;
Rituximab
;
Vincristine
4.Adverse health effects of asbestos: solving mysteries regarding asbestos carcinogenicity based on follow-up survey of a Chinese factory.
Environmental Health and Preventive Medicine 2018;23(1):35-35
The present review summarizes the results of several follow-up studies assessing an asbestos product manufacturing plant in Chongqing, China, and discusses three controversial issues related to the carcinogenicity of asbestos. The first issue is the amphibole hypothesis, which asserts that the carcinogenicity of asbestos is limited to amphiboles, such as crocidolite, but not serpentines, such as chrysotile. However, considering the possible multiple component of asbestos carcinogenicity in the presence of tobacco smoke or other carcinogens, chrysotile cannot be regarded as non-carcinogenic. Additionally, in a practical sense, it is not possible to assume "pure" chrysotile due to its ubiquitous contamination with tremolite, which is a type of amphibole. Thus, as the International Agency for Research on Cancer (IARC) assessed, all forms of asbestos including chrysotile should be regarded carcinogenic to humans (Group 1). The second issue is the chrysotile/tremolite paradox, which is a phenomenon involving predominant levels of tremolite in the lung tissues of individuals who worked in locations with negligible levels of tremolite due to the exclusive use of chrysotile. Four possible mechanisms to explain this paradox have been proposed but this phenomenon does not support the claim that amphibole is inert. The final issue discussed is the textile mystery, i.e., the higher incidence of cancer in asbestos textile plants compared to asbestos mines where the same asbestos was produced and the exposure levels were comparable. This phenomenon was first reported in North America followed by UK and then in the present observations from China. Previously, levels of fiber exposure were calculated using a universal converting coefficient to estimate the mass concentration versus fiber concentration. However, parallel measurements of fiber and mass concentrations in the workplace and exposed air indicated that there are wide variations in the fiber/mass ratio, which unjustifies the universal conversion. It is possible that contamination by airborne non-fibrous particles in mines with mass fiber conversion led to the overestimation of fiber concentrations and resulted in the textile mystery. Although the use and manufacturing of asbestos has been banned in Japan, more than 10 million tons of asbestos had been imported and the majority remains in existing buildings. Thus, efforts to control asbestos exposure should be continued.
Asbestos
;
classification
;
toxicity
;
Asbestos, Amphibole
;
toxicity
;
Asbestos, Serpentine
;
toxicity
;
Carcinogens
;
China
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms
;
chemically induced
;
epidemiology
;
Manufacturing and Industrial Facilities
;
statistics & numerical data
;
Mining
;
statistics & numerical data
;
Occupational Diseases
;
epidemiology
;
Occupational Exposure
;
adverse effects
;
Textiles
;
Tobacco Smoking
;
epidemiology
5.AZD9291-induced Acute Interstitial Lung Disease.
Ke-Ke NIE ; Xiao ZOU ; Chuan-Xin GENG ; Ling ZHANG ; Shi-Chao LIU ; Chun-Ling ZHANG ; You-Xin JI
Chinese Medical Journal 2016;129(12):1507-1508
6.The First Successful Heart-Lung Transplant in a Korean Child with Humidifier Disinfectant-Associated Interstitial Lung Disease.
Won Kyoung JHANG ; Seong Jong PARK ; Eun LEE ; Song I YANG ; Soo Jong HONG ; Ju Hee SEO ; Hyung Young KIM ; Jeong Jun PARK ; Tae Jin YUN ; Hyeong Ryul KIM ; Yong Hee KIM ; Dong Kwan KIM ; Seung Il PARK ; Sang Oh LEE ; Sang Bum HONG ; Tae Sun SHIM ; In Cheol CHOI ; Jinho YU
Journal of Korean Medical Science 2016;31(5):817-821
From 2006 to 2011, an outbreak of a particular type of childhood interstitial lung disease occurred in Korea. The condition was intractable and progressed to severe respiratory failure, with a high mortality rate. Moreover, in several familial cases, the disease affected young women and children simultaneously. Epidemiologic, animal, and post-interventional studies identified the cause as inhalation of humidifier disinfectants. Here, we report a 4-year-old girl who suffered from severe progressive respiratory failure. She could survive by 100 days of extracorporeal membrane oxygenation support and finally, underwent heart-lung transplantation. This is the first successful pediatric heart-lung transplantation carried out in Korea.
Child, Preschool
;
Disinfectants/toxicity
;
Extracorporeal Membrane Oxygenation
;
Female
;
Humans
;
*Humidifiers
;
Lung/drug effects/pathology
;
Lung Diseases, Interstitial/*chemically induced/pathology/*therapy
;
*Lung Transplantation
;
Republic of Korea
;
Respiratory Rate
;
Retrospective Studies
;
Thorax/diagnostic imaging
;
Tomography, X-Ray Computed
7.Hard metal lung disease.
Chinese Journal of Industrial Hygiene and Occupational Diseases 2015;33(7):558-560
Alloys
;
toxicity
;
Cobalt
;
toxicity
;
Humans
;
Lung Diseases
;
chemically induced
;
Tungsten
;
toxicity
8.A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin.
Se Yong KIM ; Se Jin KIM ; Doran YOON ; Seung Wook HONG ; Sehhoon PARK ; Chan Young OCK
Tuberculosis and Respiratory Diseases 2015;78(3):281-285
Statins lower the hyperlipidemia and reduce the incidence of cardiovascular events and related mortality. A 60-year-old man who was diagnosed with a transient ischemic attack was started on acetyl-L-carnitine, cilostazol, and rosuvastatin. After rosuvastatin treatment for 4 weeks, the patient presented with sudden onset fever, cough, and dyspnea. His symptoms were aggravated despite empirical antibiotic treatment. All infectious pathogens were excluded based on results of culture and polymerase chain reaction of the bronchoscopic wash specimens. Chest radiography showed diffuse ground-glass opacities in both lungs, along with several subpleural ground-glass opacity nodules; and a foamy alveolar macrophage appearance was confirmed on bronchoalveolar lavage. We suspected rosuvastatin-induced lung injury, discontinued rosuvastatin and initiated prednisolone 1 mg/kg tapered over 2weeks. After initiating steroid therapy, his symptoms and radiologic findings significantly improved. We suggest that clinicians should be aware of the potential for rosuvastatin-induced lung injury.
Acetylcarnitine
;
Bronchoalveolar Lavage
;
Chemically-Induced Disorders
;
Cough
;
Dyspnea
;
Fever
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Hyperlipidemias
;
Incidence
;
Ischemic Attack, Transient
;
Lung
;
Lung Diseases, Interstitial*
;
Lung Injury
;
Macrophages, Alveolar
;
Middle Aged
;
Mortality
;
Polymerase Chain Reaction
;
Prednisolone
;
Radiography
;
Thorax
;
Rosuvastatin Calcium
9.Rituximab-induced interstitial pneumonitis: report of two cases and literature review.
Bao-Hong PING ; Chun-Yan YUE ; Yang-Min ZHU ; Ya GAO ; Bin WU ; Jia-Qiong HONG
Journal of Southern Medical University 2015;35(1):129-132
We report two cases of rituximab (RTX)-induced interstitial pneumonia in two lymphoma patients receiving RTX treatment. Interstitial pneumonia was successfully managed in these two cases after a one-week-long intervention with corresponding treatments without affecting further treatment of the primary disease. RTX-induced interstitial pneumonia is characterized by a latent onset with an unclear pathological mechanism and absence of typical symptoms. High-resolution CT scan can provide valuable evidence for early diagnosis of RTX-induced interstitial pneumonia, which might be attributed partially to an increased susceptibility to P. jirovecii and fungal infection due to prolonged RTX treatment.
Antibodies, Monoclonal, Murine-Derived
;
adverse effects
;
Disease Susceptibility
;
Humans
;
Lung Diseases, Interstitial
;
chemically induced
;
Rituximab
;
Tomography, X-Ray Computed
10.Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
Na Ri LEE ; Ji Won JANG ; Hee Sun KIM ; Ho Young YHIM
The Korean Journal of Internal Medicine 2015;30(4):550-553
No abstract available.
Adult
;
Antineoplastic Agents/*adverse effects
;
Antitubercular Agents/therapeutic use
;
Biopsy
;
Female
;
Gastrointestinal Stromal Tumors/*drug therapy/pathology/surgery
;
Humans
;
Imatinib Mesylate/*adverse effects
;
Lung Diseases, Interstitial/*chemically induced/diagnosis
;
Mycobacterium tuberculosis/*isolation & purification
;
Protein Kinase Inhibitors/*adverse effects
;
Rectal Neoplasms/*drug therapy/pathology/surgery
;
Tomography, X-Ray Computed
;
Tuberculosis, Pulmonary/diagnosis/drug therapy/*microbiology

Result Analysis
Print
Save
E-mail